CARILLON TOWER ADVISERS, INC. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2020$37,053,000
+62.1%
330,384
-9.5%
0.23%
-25.9%
Q3 2020$22,857,000
-28.0%
365,232
-10.2%
0.30%
+24.5%
Q2 2020$31,728,000
-99.9%
406,7730.0%0.24%
+7.5%
Q1 2020$23,222,671,000
-48.8%
406,773
-28.2%
0.23%
-24.8%
Q4 2019$45,355,558,000
+108938.3%
566,1660.0%0.30%
+4.5%
Q3 2019$41,596,000
-22.1%
566,1660.0%0.29%
-21.0%
Q2 2019$53,406,000
+17.8%
566,1660.0%0.37%
+14.3%
Q1 2019$45,321,000
+48.5%
566,1660.0%0.32%
+24.4%
Q4 2018$30,522,000
-30.9%
566,1660.0%0.26%
-18.6%
Q3 2018$44,194,000566,1660.32%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders